Jill Pirhalla

Preclinical Pharmacokinetics and Interspecies Scaling of a Novel Vitronectin Receptor Antagonist

Keith W. Ward, Leonard M. Azzarano, William E. Bondinell et al. · Drug Metabolism and Disposition · 1999 · 39 citations

The metabolism and disposition of GSK2140944 in healthy human subjects

Kitaw Negash, Clara Andonian, Clive C. Felgate et al. · Xenobiotica · 2015 · 30 citations

Metabolic Disorder, Biological Mass Spectrometry, Antimicrobial Chemotherapy +22

Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers

May Y. K. Ho, Michael J. Morris, Jill Pirhalla et al. · Xenobiotica · 2013 · 27 citations

Pharmacokinetics and ADME Characterization of Intravenous and Oral [14C]-Linerixibat in Healthy Male Volunteers

Maciej J. Zamek‐Gliszczynski, David Kenworthy, David A. Bershas et al. · Drug Metabolism and Disposition · 2021 · 13 citations · Full text

Investigation of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of the HIV-1 Maturation Inhibitor GSK3640254 Using an Intravenous Microtracer Combined with EnteroTracker for Biliary Sampling

Bo Wen, Ying Zhang, Graeme Young et al. · Drug Metabolism and Disposition · 2022 · 13 citations · Full text